The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Early Identification of Refractory Epilepsy
Open accessAbstract
BACKGROUND: More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the response to antiepileptic drugs in patients with newly diagnosed epilepsy to identify factors associated with subsequent poor control of seizures. METHODS: We prospectively studied 525 patients (age, 9 to 93 years) who were given a diagnosis, treated, and followed up at a single center between 1984 and 1997. Epilepsy was classified as idiopathic (with a presumed genetic basis), symptomatic (resulting from a structural abnormality), or cryptogenic (resulting from an unknown underlying cause). Patients were considered to be seizure-free if they had not had any seizures for at least one year. RESULTS: Among the 525 patients, 333 (63 percent) remained seizure-free during antiepileptic-drug treatment or after treatment was stopped. The prevalence of persistent seizures was higher in patients with symptomatic or cryptogenic epilepsy than in those with idiopathic epilepsy (40 percent vs. 26 percent, P=0.004) and in patients who had had more than 20 seizures before starting treatment than in those who had had fewer (51 percent vs. 29 percent, P<0.001). The seizure-free rate was similar in patients who were treated with a single established drug (67 percent) and patients who were treated with a single new drug (69 percent). Among 470 previously untreated patients, 222 (47 percent) became seizure-free during treatment with their first antiepileptic drug and 67 (14 percent) became seizure-free during treatment with a second or third drug. In 12 patients (3 percent) epilepsy was controlled by treatment with two drugs. Among patients who had no response to the first drug, the percentage who subsequently became seizure-free was smaller (11 percent) when treatment failure was due to lack of efficacy than when it was due to intolerable side effects (41 percent) or an idiosyncratic reaction (55 percent). CONCLUSIONS: Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the remaining 30% have drug-resistant epilepsy requiring consideration of surgical intervention, ketogenic dietary therapy, vagus nerve stimulation, or other neuromodulatory approaches6,7”
In the citing paper
“While approximately 70% of patients can achieve seizure freedom with appropriate antiepileptic drug (AED) therapy”
Citations
Cites
Guidelines for Epidemiologic Studies on Epilepsy
(1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb00433.x · Cited by 1,360
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M., Adam, C., Broglin, D., Arzimanoglou, A. A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,105
Engel, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603073341008 · Cited by 880
Long-Term Prognosis of Seizures with Onset in Childhood
Sillanpää, M. L., Jalava, M., Kaleva, O., & Shinnar, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382402 · Cited by 725
Remission of Seizures and Relapse in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Elveback, L. R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04857.x · Cited by 621
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. W. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 614
Self-citationMDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N. M., Annett, G., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 529
Multidrug resistance: molecular mechanisms and clinical relevance
Ling, V. W. T. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051053 · Cited by 525
Brodie, M. J., Overstall, P. W., & Giorgi, L. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00039-x · Cited by 462
Self-citation
Research works printed but not linked: 2
- Dreifuss FE. Classification of epileptic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:517-24.
- Wolf P. International classification of the epilepsies. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:773-7.
Cited by
Sorted by citations
Items 201–300 of 1,005
Klitgaard, H., Matagne, A., Nicolas, J., Gillard, M., Lamberty, Y., De Ryck, M., Kaminski, R. M., Leclercq, K., Niespodziany, I., Wolff, C., et al. (2016) · Epilepsia · doi:10.1111/epi.13340 · Cited by 168
Benabid, A. L., Minotti, L., Koudsié, A., Martin, A. D. S., & Hirsch, É. (2002) · Neurosurgery · doi:10.1097/00006123-200206000-00037 · Cited by 171
When should temporal-lobe epilepsy be treated surgically?
Spencer, S. S. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00163-1 · Cited by 171
Vetkas, A., Fomenko, A., Germann, J., Sarica, C., Iorio‐Morin, C., Samuel, N., Yamamoto, K., Milano, V., Cheyuo, C., Zemmar, A., et al. (2022) · Epilepsia · doi:10.1111/epi.17157 · Cited by 170
Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
Rawat, C., Kukal, S., Dahiya, U. R., & Kukreti, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1592-3 · Cited by 162
Comparing SVM and convolutional networks for epileptic seizure prediction from intracranial EEG
Mirowski, P., LeCun, Y., Madhavan, D., & Kuzniecky, R. (2008) · Machine learning for signal processing ... · doi:10.1109/mlsp.2008.4685487 · Cited by 172
Noè, F. M., Pool, A., Nissinen, J., Gobbi, M., Bland, R. J., Rizzi, M., Balducci, C., Ferraguti, F., Sperk, G., During, M. J., et al. (2008) · Brain · doi:10.1093/brain/awn079 · Cited by 170
Volk, H. A., & Löscher, W. (2005) · Brain · doi:10.1093/brain/awh437 · Cited by 170
Response to first drug trial predicts outcome in childhood temporal lobe epilepsy
Dlugos, D., Sammel, M. D., Strom, B. L., & Farrar, J. T. (2001) · Neurology · doi:10.1212/wnl.57.12.2259 · Cited by 170
Beydoun, A. A., D’Souza, J., Hebert, D., & Doty, P. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.1.33 · Cited by 169
Surgical treatment for epilepsy: the potential gap between evidence and practice
Jetté, N., Sander, J. W. A. S., & Keezer, M. R. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30127-2 · Cited by 169
The burden of epilepsy and unmet need in people with focal seizures
Ioannou, P., Foster, D. L., Sander, J. W. A. S., Dupont, S., Gil‐Nagel, A., O’Flaherty, E. D., Álvarez‐Barón, E., & Medjedovic, J. (2022) · Brain and Behavior · doi:10.1002/brb3.2589 · Cited by 168
“Approximately 40% of people with epilepsy may be drug-resistant (DRE1), deriving no benefit from two ASMs (Chen et al., 2018; Kwan & Brodie, 2000).”
BackgroundEpileptic seizures and syndromes
Benbadis, S. R. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70018-9 · Cited by 168
Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome
Rao, S. C., Dove, G., Cascino, G. D., & Petersen, R. C. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.08.012 · Cited by 167
Nakamura, M., Cho, J., Shin, H., & Jang, I. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.05.007 · Cited by 166
Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy
Holland, K. D., Kearney, J. A., Glauser, T. A., Buck, G., Keddache, M. A., Blankston, J. R., Glaaser, I. W., Kass, R. S., & Meisler, M. H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.064 · Cited by 166
Mechanisms of antiepileptic drug resistance
Sisodiya, S. M. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200304000-00013 · Cited by 164
Medicinal compounds with antiepileptic/anticonvulsant activities
Zhu, H., Wan, J., Wang, Y., Li, B., Cheng, X., He, J., & Li, P. (2013) · Epilepsia · doi:10.1111/epi.12463 · Cited by 162
Comparative retention rates and long-term tolerability of new antiepileptic drugs
Chung, S. S., Wang, N. C., & Hank, N. C. (2007) · Seizure · doi:10.1016/j.seizure.2007.01.004 · Cited by 161
Ketogenic diet for epilepsy treatment
Sampaio, L. P. D. B. (2016) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20160116 · Cited by 161
An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy
Wang, Y., & Chen, Z. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.010 · Cited by 157
Rambeck, B., Jürgens, U. H., May, T. W., Pannek, H. W., Behne, F., Ebner, A., Gorji, A., Straub, H., Speckmann, E., Pohlmann‐Eden, B., et al. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00504.x · Cited by 161
Refractory epilepsy: a progressive, intractable but preventable condition?
Kwan, P., & Brodie, M. J. (2002) · Seizure · doi:10.1053/seiz.2002.0593 · Cited by 161
Self-citationDeep brain and cortical stimulation for epilepsy
Sprengers, M., Vonck, K. E. J., Carrette, E., Marson, A. G., & Boon, P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008497.pub3 · Cited by 159
Beghi, E., Gatti, G., Tonini, C., Ben‐Menachem, E., Chadwick, D. W., Nikanorova, M., Gromov, S. A., Smith, P. E. M., Specchio, L. M., & Perucca, E. (2003) · Epilepsy Research · doi:10.1016/j.eplepsyres.2003.09.007 · Cited by 159
New epilepsy therapies in development
Klein, P., Kaminski, R. M., Koepp, M. J., & Löscher, W. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00981-w · Cited by 166
“NKCC1 is expressed as two splice variants, NKCC1a and NKCC1b, which differ by alternative splicing of exon 21 (ref.”
New-onset temporal lobe epilepsy in children
Spooner, C. G., Berkovic, S. F., Mitchell, L. A., Wrennall, J. A., & Harvey, A. S. (2006) · Neurology · doi:10.1212/01.wnl.0000248189.93630.4f · Cited by 157
Early Seizure Detection Algorithm Based on Intracranial EEG and Random Forest Classification
Donos, C., Dümpelmann, M., & Schulze‐Bonhage, A. (2015) · International Journal of Neural Systems · doi:10.1142/s0129065715500239 · Cited by 157
Gliske, S., Irwin, Z. T., Chestek, C. A., Hegeman, G. L., Brinkmann, B. H., Sagher, O., Garton, H. J. L., Worrell, G. A., & Stacey, W. C. (2018) · Nature Communications · doi:10.1038/s41467-018-04549-2 · Cited by 157
Luo, X., Cheng, Z., Wang, R., & Yu, F. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04529 · Cited by 157
ABCB1 Polymorphisms Influence the Response to Antiepileptic Drugs in Japanese Epilepsy Patients
Seo, T., Ishitsu, T., Ueda, N., Nakada, N., Yurube, K., Ueda, K., & Nakagawa, K. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.4.551 · Cited by 157
Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy
Wang, J., Tan, L., Tan, L., Tian, Y., Ma, J., Tan, C., Wang, H.-F., Liu, Y., Tan, M., Jiang, T., et al. (2015) · Scientific Reports · doi:10.1038/srep10201 · Cited by 153
EpiTools, A software suite for presurgical brain mapping in epilepsy: Intracerebral EEG
Villalon, S. M., Paz, R. M., Roehri, N., Lagarde, S., Pizzo, F., Colombet, B., Bartoloméi, F., Carron, R., & Bénar, C. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.03.018 · Cited by 154
Lee, K. J., Jang, K., & Shon, Y. (2007) · Springer eBooks · doi:10.1007/978-3-211-35205-2_17 · Cited by 155
Remission of epilepsy after two drug failures in children: A prospective study
Berg, A. T., Levy, S. R., Testa, F. M., & D'Souza, R. (2009) · Annals of Neurology · doi:10.1002/ana.21642 · Cited by 154
Vagal Nerve Stimulation in Refractory Epilepsy
Murphy, J. V., Torkelson, R. D., Dowler, I., Simon, S. D., & Hudson, S. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.6.560 · Cited by 152
Drug-Resistant Epilepsy and Surgery
Sheng, J., Shui, L., Qin, H., Li, B., & Zhang, X. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170504123316 · Cited by 149
A novel no-equilibrium HR neuron model with hidden homogeneous extreme multistability
Zhang, S., Zheng, J., Wang, X., & Zeng, Z. (2021) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2021.110761 · Cited by 151
Bhatti, S. F. M., Risio, L. D., Muñana, K. R., Penderis, J., Stein, V. M., Tipold, A., Berendt, M., Farquhar, R. G., Fischer, A., Long, S., et al. (2015) · BMC Veterinary Research · doi:10.1186/s12917-015-0464-z · Cited by 150
Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies
Guery, D., & Rheims, S. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s256699 · Cited by 165
A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy
Lambrechts, D. A. J. E., de Kinderen, R. J. A., Vles, J. S. H., de Louw, A. J. A., Aldenkamp, A. P., & Majoie, M. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12592 · Cited by 150
Beyenburg, S., Stavem, K., & Schmidt, D. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02299.x · Cited by 149
Risk factors for drug-resistant epilepsy
Xue-Ping, W., Wang, H., Zhu, L., Xu, D., & Liu, L. (2019) · Medicine · doi:10.1097/md.0000000000016402 · Cited by 159
A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy
Gilliam, F. G., Veloso, F., Bomhof, M. A. M., Gazda, S. K., Biton, V., ter Bruggen, J. P., Neto, W., Bailey, C., Pledger, G. W., Wu, S., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000048200.12663.bc · Cited by 149
Temporal Lobe Epilepsy Surgery Failures: A Review
Harroud, A., Bouthillier, A., Weil, A. G., & Nguyen, D. K. (2012) · Epilepsy Research and Treatment · doi:10.1155/2012/201651 · Cited by 150
Seizure outcome of pediatric epilepsy surgery
Widjaja, E., Jain, P., Demoe, L., Guttmann, A., TOMLINSON, G. A., & Sander, B. (2020) · Neurology · doi:10.1212/wnl.0000000000008966 · Cited by 151
Withdrawal of antiepileptic drugs: Guidelines of the I talian L eague A gainst E pilepsy
Beghi, E., Giussani, G., Grosso, S., Iudice, A., Neve, A. L., Pisani, F., Specchio, L. M., Verrotti, A., Capovilla, G., Michelucci, R., et al. (2013) · Epilepsia · doi:10.1111/epi.12305 · Cited by 147
Predicting pharmacoresistance in pediatric epilepsy
Wirrell, E. C. (2013) · Epilepsia · doi:10.1111/epi.12179 · Cited by 147
CONTROL OF SYNCHRONIZATION OF BRAIN DYNAMICS LEADS TO CONTROL OF EPILEPTIC SEIZURES IN RODENTS
Good, L. B., Sabesan, S., Marsh, S. T., Tsakalis, K. S., Treiman, D. M., & Iasemidis, L. D. (2009) · International Journal of Neural Systems · doi:10.1142/s0129065709001951 · Cited by 145
Tellez-Zenteno, J. F., Hernández‐Ronquillo, L., Buckley, S., Zahagun, R., & Rizvi, S. (2014) · Epilepsia · doi:10.1111/epi.12633 · Cited by 145
Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy
Liimatainen, S., Peltola, M., Sabater, L., Fallah, M., Kharazmi, E., Haapala, A., Dastidar, P., Knip, M., Saiz, A., & Peltola, J. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02325.x · Cited by 144
Brodie, M. J., Rosenfeld, W. E., Vázquez, B., Sachdeo, R., Perdomo, C. A., Mann, A., & Arroyo, S. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02160.x · Cited by 144
Self-citationEpilepsies associated with hippocampal sclerosis
Cendes, F., Sakamoto, A. C., Spreafico, R., Bingaman, W. E., & Becker, A. J. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1292-0 · Cited by 152
Nicolson, A., Appleton, R. E., Chadwick, D. W., & Smith, D. (2004) · PubMed Central · Cited by 144
Carbamazepine is not a substrate for P‐glycoprotein
Owen, A., Pirmohamed, M., Tettey, J. N. A., Morgan, P., Chadwick, D. W., & Park, B. K. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01359.x · Cited by 144
Data mining neocortical high-frequency oscillations in epilepsy and controls
Blanco, J. A., Stead, M., Krieger, A. Μ., Stacey, W. C., Maus, D. C., Marsh, E. D., Viventi, J., Lee, K. H., Marsh, R., Litt, B., et al. (2011) · Brain · doi:10.1093/brain/awr212 · Cited by 143
Satishchandra, P., Santhosh, N., & Sinha, S. (2014) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.128643 · Cited by 141
Vagus Nerve Stimulation for Epilepsy and Depression
Milby, A. H., Halpern, C. H., & Baltuch, G. H. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.10.071 · Cited by 141
Precise detection of low-level somatic mutation in resected epilepsy brain tissue
Sim, N. S., Ko, A., Kim, W. K., Kim, S. H., Kim, J. S., Shim, K.-W., Aronica, E., Mijnsbergen, C., Spliet, W. G. M., Koh, H. Y., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02052-6 · Cited by 137
Microglial depletion aggravates the severity of acute and chronic seizures in mice
Wu, W., Li, Y., Wei, Y., Bosco, D. B., Xie, M., Zhao, M., Richardson, J. R., & Wu, L. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.028 · Cited by 133
Neuropathology of the blood–brain barrier and pharmaco-resistance in human epilepsy
Liu, J. Y. W., Thom, M., Catarino, C. B., Martinian, L., Figarella-Branger, D. F., Bartoloméi, F., Koepp, M. J., & Sisodiya, S. M. (2012) · Brain · doi:10.1093/brain/aws147 · Cited by 141
The global cost of epilepsy: A systematic review and extrapolation
Begley, C. E., Wagner, R. G., Abraham, A., Beghi, E., Newton, C. R. J. C., Kwon, C., Labiner, D. M., & Winkler, A. S. (2022) · Epilepsia · doi:10.1111/epi.17165 · Cited by 139
Deep Brain Stimulation for Epilepsy
Halpern, C. H., Samadani, U., Litt, B., Jaggi, J. L., & Baltuch, G. H. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.10.065 · Cited by 138
The vagus afferent network: emerging role in translational connectomics
Hachem, L. D., Wong, S. M., & Ibrahim, G. M. (2018) · Neurosurgical FOCUS · doi:10.3171/2018.6.focus18216 · Cited by 138
Long‐term antiepileptic drug therapy contributes to the acceleration of atherosclerosis
Tan, T., Lu, C., Chuang, H., Lin, T., Liou, C., Chang, W., & Chuang, Y. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02024.x · Cited by 137
Strzelczyk, A., Griebel, C., Lux, W., Rosenow, F., & Reese, J. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00712 · Cited by 136
Comprehensive presurgical functional MRI language evaluation in adult patients with epilepsy
Szaflarski, J. P., Holland, S. K., Jacola, L. M., Lindsell, C. J., Privitera, M., & Szaflarski, M. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.07.015 · Cited by 137
Minimizing AED Adverse Effects: Improving Quality of Life in the Interictal State in Epilepsy Care
Louis, E. K. S. (2009) · Current Neuropharmacology · doi:10.2174/157015909788848857 · Cited by 135
Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials
Rief, W., Bingel, U., Schedlowski, M., & Enck, P. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.204 · Cited by 135
Shorvon, S. D., & Goodridge, D. M. (2013) · Brain · doi:10.1093/brain/awt223 · Cited by 134
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia
Calabresi, P., Cupini, L. M., Centonze, D., Pisani, F., & Bernardi, G. (2003) · Annals of Neurology · doi:10.1002/ana.10603 · Cited by 133
Anterior Nucleus Deep Brain Stimulation for Refractory Epilepsy
Krishna, V., King, N. K. K., Sammartino, F., Strauss, I., Andrade, D. M., Wennberg, R. A., & Lozano, A. M. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001197 · Cited by 133
Schmidt, D., & Stavem, K. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01997.x · Cited by 133
Kobau, R., DiIorio, C. A., Price, P. H., Thurman, D. J., Martin, L. M., Ridings, D. L., & Henry, T. R. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.02.007 · Cited by 133
Channelopathies in Idiopathic Epilepsy
Heron, S. E., Scheffer, I. E., Berkovic, S. F., Dibbens, L. M., & Mulley, J. C. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.01.009 · Cited by 132
Teixeira, C., Direito, B., Bandarabadi, M., Quyen, M. L. V., Valderrama, M., Schelter, B. O., Schulze‐Bonhage, A., Navarro, V., Sales, F., & Dourado, A. (2014) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2014.02.007 · Cited by 133
The Epigenetics of Epilepsy and Its Progression
Hauser, R. M., Henshall, D. C., & Lubin, F. D. (2017) · The Neuroscientist · doi:10.1177/1073858417705840 · Cited by 135
Xu, D., Robinson, A. P., Ishii, T., Duncan, D. S., Alden, T. D., Goings, G. E., Ifergan, I., Podojil, J. R., Penaloza‐MacMaster, P., Kearney, J. A., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171285 · Cited by 136
Complications of vagal nerve stimulation for drug-resistant epilepsy
Kahlow, H., & Olivecrona, M. (2013) · Seizure · doi:10.1016/j.seizure.2013.06.011 · Cited by 132
Louis, E. K. S. (2009) · Current Neuropharmacology · doi:10.2174/157015909788848929 · Cited by 131
Long-Term Outcome of Anterior Thalamic Nucleus Stimulation for Intractable Epilepsy
Lee, K. J., Shon, Y. M., & Cho, C. B. (2012) · Stereotactic and Functional Neurosurgery · doi:10.1159/000339991 · Cited by 131
Chaotic dynamics in a neural network with different types of external stimuli
Lin, H., Wang, C., Yao, W., & Tan, Y. (2020) · Communications in Nonlinear Science and Numerical Simulation · doi:10.1016/j.cnsns.2020.105390 · Cited by 131
New horizons in the development of antiepileptic drugs
Löscher, W., & Schmidt, D. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00063-3 · Cited by 131
Kellinghaus, C., & Lüders, H. O. (2004) · Epileptic Disorders · doi:10.1684/j.1950-6945.2004.tb00071.x · Cited by 131
A Pilot Study of a Yoga Meditation Protocol for Patients with Medically Refractory Epilepsy
Rajesh, B., Jayachandran, D., Mohandas, G., & Radhakrishnan, K. (2006) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2006.12.367 · Cited by 130
Empirical evidence of underutilization of referrals for epilepsy surgery evaluation
de Flon, P., Kumlien, E., Reuterwall, C., & Mattsson, P. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02891.x · Cited by 130
Forecasting Seizures in Dogs with Naturally Occurring Epilepsy
Howbert, J. J., Patterson, E. E., Stead, S. M., Brinkmann, B. H., Vasoli, V. M., Crepeau, D., Vite, C. H., Sturges, B. K., Ruedebusch, V., Mavoori, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0081920 · Cited by 129
Behr, C., Goltzène, M.-A., Kosmalski, G., Hirsch, É., & Ryvlin, P. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2015.11.003 · Cited by 129
Clinical 7 T MRI: Are we there yet? A review about magnetic resonance imaging at ultra-high field
Barisano, G., Sepehrband, F., Ma, S. J., Jann, K., Cabeen, R. P., Wang, D. J. J., Toga, A. W., & Law, M. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180492 · Cited by 141
Żarnowska, I. (2020) · Nutrients · doi:10.3390/nu12092616 · Cited by 141
Zhang, S., Zheng, J., Wang, X., & Zeng, Z. (2021) · Chaos An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/5.0035595 · Cited by 129
Epilepsy surgery: A critical review
Noachtar, S., & Borggraefe, I. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.02.028 · Cited by 129
Loacker, S., Sayyah, M., Wittmann, W., Herzog, H., & Schwarzer, C. (2007) · Brain · doi:10.1093/brain/awl384 · Cited by 128
Kwan, P., Poon, W. S., Ng, H., Kang, D. E., Wong, V. C. N., Ng, P. W., Lui, C. H. T., Sin, N. C., Wong, K. S., & Baum, L. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283117d67 · Cited by 127
Self-citationBenifla, M., Rutka, J. T., Logan, W. J., & Donner, E. J. (2006) · Child s Nervous System · doi:10.1007/s00381-006-0123-6 · Cited by 127
The Role of Stereotactic Laser Amygdalohippocampotomy in Mesial Temporal Lobe Epilepsy
Gross, R. E., Willie, J. T., & Drane, D. L. (2015) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2015.08.004 · Cited by 127
Disease modification in partial epilepsy
Walker, M. C. (2002) · Brain · doi:10.1093/brain/awf203 · Cited by 127
Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice
Bhutada, P., Mundhada, Y. R., Bansod, K. U., Dixit, P. V., Umathe, S. N., & Mundhada, D. R. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.03.007 · Cited by 126
Antioxidants as a Preventive Treatment for Epileptic Process: A Review of the Current Status
Martinc, B., Grabnar, I., & Vovk, T. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140923205715 · Cited by 126
Early predictors of outcome in newly diagnosed epilepsy
Mohanraj, R., & Brodie, M. J. (2013) · Seizure · doi:10.1016/j.seizure.2013.02.002 · Cited by 126
Self-citation
Metadata
- Authors
- Kwan, P., & Brodie, M. J.
- Affiliations
- Western Infirmary (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-02-03
- Volume
- 342
- Issue
- 5
- Pages
- 314-319
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1974809694
- Cited by
- 5,204
- References
- 39
- Citations by year
- 2026: 225 · 2025: 241 · 2024: 259 · 2023: 275 · 2022: 269 · 2021: 328 · 2020: 348 · 2019: 253 · 2018: 270 · 2017: 228 · 2016: 249 · 2015: 230 · 2014: 205 · 2013: 233 · 2012: 248
- FWCI
- 55.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- CRC Press eBooks (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- drug-resistant epilepsy, antiepileptic drugs, seizure control, newly diagnosed epilepsy, idiopathic epilepsy, symptomatic epilepsy, cryptogenic epilepsy, seizure frequency, predictors of treatment failure, adverse drug reactions, polypharmacy
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Anticonvulsants, Child, Epilepsy, Female, Humans, Male, Middle Aged, Prospective Studies, Remission Induction, Treatment Failure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review